Disclosures for "Ubrogepant for the Acute Treatment of Migraine When Administered During the Prodrome (Premonitory Phase): Results From a Phase 3, Randomized, Double-blind, Placebo-Controlled, Crossover Study")
-
Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AEON. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerecin. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WL Gore. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pieris. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Revance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equinox . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cooltech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CtrlM. An immediate family member of Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. An immediate family member of Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Dodick has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cooltech. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for All companies listed as consultant also apply to advisory board. . Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Epien. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received stock or an ownership interest from Healint. Dr. Dodick has received stock or an ownership interest from Theranica. Dr. Dodick has received stock or an ownership interest from Aural Analytics . Dr. Dodick has received stock or an ownership interest from Epien. Dr. Dodick has received stock or an ownership interest from Matterhorn. Dr. Dodick has received stock or an ownership interest from Ontologics. Dr. Dodick has received stock or an ownership interest from Precon Health. Dr. Dodick has received stock or an ownership interest from King Devick Technologies. Dr. Dodick has received stock or an ownership interest from Nocira. Dr. Dodick has received stock or an ownership interest from Exsano. Dr. Dodick has received stock or an ownership interest from Palion. Dr. Dodick has received stock or an ownership interest from Second opinion/mobile health. Dr. Dodick has received stock or an ownership interest from AYYA Biosciences. Dr. Dodick has received stock or an ownership interest from Perfood. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from American Migraine Foundation. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a CME symposia with CME Outfitters. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a CME symposia speaker with WebMD/Medscape. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consulting with KLJ Associates. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consulting with Curry Rockefeller Group. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consulting with DeepBench. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a CME symposia speaker with Medlogix Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a CME symposia speaker with Miller Medical Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a speaker at annual meeting with Southern Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a consulting with Majallin LLC. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consulting/Advisory board with Satsuma. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a CME symposia speakers with Global Access Meetings. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
-
Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon BioPharmaceuticals. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli-Lilly. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddys. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biodelivery Sciences International. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon Biopharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from Celgene. The institution of Dr. Goadsby has received research support from Eli-Lilly. The institution of Dr. Goadsby has received research support from Visual Snow Initiative. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Executive roles with American Headache Society that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Scientific Officer with British Association for the Study of Headache that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Director with American Migraine Foundation that is relevant to AAN interests or activities.
-
Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix Pharma. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Science. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Schwedt has stock in Aural Analytics. Dr. Schwedt has stock in Nocira. The institution of Dr. Schwedt has received research support from Amgen. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from SPARK Neuro. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
-
Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from NIH. The institution of Dr. Lipton has received research support from NINDS. The institution of Dr. Lipton has received research support from NIH. The institution of Dr. Lipton has received research support from NIA. The institution of Dr. Lipton has received research support from NIH. The institution of Dr. Lipton has received research support from NIA. The institution of Dr. Lipton has received research support from NIH. The institution of Dr. Lipton has received research support from Veterans Administration. The institution of Dr. Lipton has received research support from NIH. Dr. Lipton has received publishing royalties from a publication relating to health care.
-
Chengcheng Liu has received personal compensation for serving as an employee of AbbVie. Chengcheng Liu has received stock or an ownership interest from AbbVie.
-
Kaifeng Lu has received personal compensation for serving as an employee of AbbVie. Kaifeng Lu has stock in AbbVie. Kaifeng Lu has stock in Beigene.
-
Ms. Yu has received stock or an ownership interest from AbbVie.
-
Lawrence Severt has nothing to disclose.
-
Michelle Finnegan has received personal compensation for serving as an employee of AbbVie.
-
Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.